Similar to other deleterious effects of reduced DRD1 expression in NSCLC tumors reported in the present study, we found that patients in the DRD1‐low expression groups had significantly worse survival compared those in the DRD1‐high expression groups in both datasets (Fig. 3F). The gene discussed is DRD1; the disease is non-small cell lung carcinoma.